Silicon Laboratories INC Schedule 13G passive stakes

Vanguard Capital Management has reported a beneficial ownership of 5.23% in Silicon Laboratories Inc. common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 6.57% in Silicon Laboratories Inc. common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Silicon Laboratories Inc. common stock following an internal realignment.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 2.1% beneficial ownership stake in Silicon Laboratories Inc. as of February 27, 2026.

Capital Research Global Investors has reported a 3.7% beneficial ownership stake in Silicon Laboratories Inc., holding 1,206,937 shares of common stock.

BlackRock, Inc. has filed an updated Schedule 13G, revealing a 12.5% beneficial ownership stake in Silicon Laboratories Inc., totaling over 4 million shares.

Capital Research Global Investors, an investment adviser, has disclosed a 6.6% passive beneficial ownership stake in Silicon Laboratories Inc. as of December 31, 2024.